Brian Lee MD
Hepatology & Liver Transplantation
Hepatologist, Digestive Health Institute, Hoag Health
Join to View Full Profile
500 Superior Ave, Suite 100Newport Beach, CA 92663
Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Brian Lee is a physician based in Orange County, CA, with a specialty in Hepatology and Liver Transplantation. Dr. Lee completed his educational journey at multiple centers, including his medical degree at Rush Medical College in Chicago, IL. He completed Residency in Internal Medicine and Fellowship in Gastroenterology at the University of Southern California in Los Angeles, CA. He then completed a Fellowship in Transplant Hepatology at the Icahn School of Medicine at Mount Sinai in New York, NY.
He currently serves as the Director of the Hoag Liver Program and as an Associate Consultant for the Hoag Digestive Health Institute. Dr. Lee has experience with a range of liver conditions, and he has published multiple papers in reputable medical journals on these topics. He currently serves as a principle investigator for clinical trials in MASH therapeutics. He also serves on several hospital committees for quality improvement in cirrhosis.
Education & Training
Icahn School of Medicine at Mount SinaiFellowship, Transplant Hepatology, 2019 - 2020
University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Gastroenterology, 2016 - 2019- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 2013 - 2016
Rush Medical College of Rush University Medical CenterClass of 2013, MD
Certifications & Licensure
CA State Medical License Active through 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Clinical Trials
- A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis Start of enrollment: 2023 Dec 01
- A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH Start of enrollment: 2024 Sep 04
Publications & Presentations
PubMed
- Defining Risk in Alcohol-Associated Liver Disease Using the Model for End-Stage Liver Disease.Richard Parker, Guru Aithal, Michael Allison, Mayur Brahmania, Ewan Forrest
The American Journal of Gastroenterology. 2025-07-17 - 1 citationsMedications for Weight Loss and MASLD: A National Survey of Hepatology and Gastroenterology Provider Practices, Attitudes, and Knowledge Before Resmetirom.Gene Y Im, Amon Asgharpour, Elizabeth S Aby, Jonathan G Stine, Jessica L Mellinger
Journal of Clinical Gastroenterology. 2025-06-23 - 1 citationsDifferential Effects of Ascites and Hepatic Encephalopathy on Waitlist Mortality in Liver Transplantation by MELD 3.0.Brian T Lee, Nathan T Chen, Tse-Ling Fong, Jennifer L Dodge
Transplantation Direct. 2024-06-01
Journal Articles
- Amebic Liver Abscess Masquerading Like Pyogenic Hepatic Abscess: Get the Anchovy Sauce.Lee BT, Kaplowitz N., Ann Clin Case Rep. 2016; 1: 1050., 7/21/2016
Books/Book Chapters
Professional Memberships
- American Association for the Study of Liver Diseases - AASLDMember
- American Society of Transplantation - ASTMember
- Member
Other Languages
- Spanish, Korean
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
